ALK-001 (C20-D3-Vitamin A) slows the growth of atrophic lesions in ABCA4-related Stargardt Disease: Results of a Phase 2 placebo-controlled clinical trial (TEASE study)
Investigative Ophthalmology & Visual Science. 2022.
Learn More
C20D3-Vitamin A Prevents Retinal Pigment Epithelium Atrophic Changes in a Mouse Model
Transl Vis Sci Technol. 2021
Learn More
TEASE: a phase 2 clinical trial assessing the tolerability and effects of oral once-a-day ALK-001 on Stargardt disease
ARVO Annual Meeting Abstract. 2016
Learn More